12.97 (-%)
As of Nov 21, 2024
Source:
Greenwich Lifesciences, Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrencesin patients who have previously undergone surgery.
| Country | United States |
| Headquarters | stafford, texas |
| Phone Number | 203-434-3290 |
| Industry | |
| CEO | Snehal Patel |
| Website | greenwichlifesciences.com |